This study is completed in the United States, in India, in Romania, .... It is testing extended Release Paliperidone for schizophrenia.
SchizophreniaDrugFrom 12 Years to 17 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether the Efficacy and Safety of Extended Release Paliperidone may be useful for adolescents experiencing schizophrenia.
What would participation involve?
Participants may receive the Efficacy and Safety of Extended Release Paliperidone, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in India, in Romania, and in Russia.
Who is it mainly for?
This study appears to be mainly for adolescents with schizophrenia. Because it involves minors, a parent or guardian may need to be involved.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateAugust 2007
Recruitment status
Completed
Enrollment listed in the registry
201
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, India, Romania, ...
Age range
From 12 Years to 17 Years
Official registry ID
NCT00518323
Official title
A Randomized, Multicenter, Double-Blind, Weight-Based, Fixed-Dose, Parallel-Group, Placebo-Controlled Study of the Efficacy and Safety of Extended Release Paliperidone for the Treatment of Schizophrenia in Adolescent Subjects, 12 to 17 Years of Age
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
India · 7 sites
Bangalore
Bangalore
Site status: Not listed — confirm with the team
Chennai
Chennai
Site status: Not listed — confirm with the team
Hyderabad
Hyderabad
Site status: Not listed — confirm with the team
Hyderabad Andra Pradesh
Hyderabad Andra Pradesh
Site status: Not listed — confirm with the team
Mangalore
Mangalore
Site status: Not listed — confirm with the team
New Delhi
New Delhi
Site status: Not listed — confirm with the team
Varanasi
Varanasi
Site status: Not listed — confirm with the team
Romania · 1 site
Bucharest
Bucharest
Site status: Not listed — confirm with the team
Russia · 11 sites
Ekaterinburg Na
Ekaterinburg Na
Site status: Not listed — confirm with the team
Kazan'
Kazan'
Site status: Not listed — confirm with the team
Moscow
Moscow
Site status: Not listed — confirm with the team
Moscow Russia
Moscow Russia
Site status: Not listed — confirm with the team
Nizhny Novgorod
Nizhny Novgorod
Site status: Not listed — confirm with the team
Saint Petersburg
Saint Petersburg
Site status: Not listed — confirm with the team
Saratov
Saratov
Site status: Not listed — confirm with the team
Smolensk Region N/A
Smolensk Region N/A
Site status: Not listed — confirm with the team
Stavropol Na
Stavropol Na
Site status: Not listed — confirm with the team
Tomsk Na
Tomsk Na
Site status: Not listed — confirm with the team
Yaroslavl
Yaroslavl
Site status: Not listed — confirm with the team
Ukraine · 5 sites
Hlevakha
Hlevakha
Site status: Not listed — confirm with the team
Kharkiv
Kharkiv
Site status: Not listed — confirm with the team
Kiev
Kiev
Site status: Not listed — confirm with the team
Odesa
Odesa
Site status: Not listed — confirm with the team
Simferopol
Simferopol
Site status: Not listed — confirm with the team
United States · 10 sites
Cerritos
Cerritos, California
Site status: Not listed — confirm with the team
Fountain Valley
Fountain Valley, California
Site status: Not listed — confirm with the team
San Diego
San Diego, California
Site status: Not listed — confirm with the team
Santa Ana
Santa Ana, California
Site status: Not listed — confirm with the team
Washington D.C.
Washington D.C., District of Columbia
Site status: Not listed — confirm with the team
Lake Charles
Lake Charles, Louisiana
Site status: Not listed — confirm with the team
Boston
Boston, Massachusetts
Site status: Not listed — confirm with the team
Cleveland
Cleveland, Ohio
Site status: Not listed — confirm with the team
Portsmouth
Portsmouth, Virginia
Site status: Not listed — confirm with the team
Spokane
Spokane, Washington
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00518323. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Paliperidone ER, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 12 Years to 17 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
